Related Experiment Video
Updated: Jun 28, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
[Transfusion requirements in chronic kidney disease]
1Service de néphrologie, hôpitaux de Brabois, CHU de Nancy, Vandoeuvre-lès-Nancy, France. l.frimat@chu-nancy.fr
Abstract:
Population-based study suggests that chronic kidney disease is frequent. Almost one third of people older than 70 years of age would have a significant decrease in renal function. Anemia appears when glomerular filtration rate falls under 40mL per minute per 1.73m(2). Concurrently with supplementary iron, erythropoiesis-stimulating agents (ESA) allow a strict control of hemoglobin. However, incomplete responses to ESA are possible. The following conditions - inflammatory disorders, chronic blood loss, hyperparathyroidism, surgical process, chronic diseases, adverse effects of immunosuppressive agents - may cause apparent resistance to ESA therapy. All these conditions may request transfusion.
Related Concept Videos
Kidney Transplant I: Introduction
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease III: Interprofessional Care
Kidney Transplant III: Nursing Management
Kidney Transplant II: Surgical Procedure
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
